Boardroom Alpha
Meeting calendar
HR · Annual meeting · Tuesday, May 19, 2026

Healthcare Realty Trust Inc

6 nominees · 3 ballot items.

Elect six directors; ratify Deloitte & Touche LLP as independent auditors for 2026; and approve, on a non-binding advisory basis, the Company’s executive compensation (say-on-pay).

Market cap
$7.4B
1Y TSR
+35.1%
Board grade
B
Record date
Mar 26, 2026
Filing
DEF 14A
Meeting concluded · May 19, 2026

Follow how the vote landed and what changed on Healthcare Realty Trust Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Elect six nominees as directors to serve one-year terms expiring at the 2027 annual meeting.

  2. 2

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the Audit Committee’s selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for fiscal year 2026.

  3. 3

    Non-Binding Advisory Vote on Executive Compensation

    ManagementBoard: FOR

    Advisory (non-binding) 'say-on-pay' vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement.

    More detail

    This proposal asks shareholders to cast a non-binding advisory vote to approve the Company’s disclosed compensation of its named executive officers (a "say-on-pay" vote). Management and the Compensation and Human Capital Committee seek shareholder approval to confirm that the Company’s compensation framework — which relies heavily on at-risk, performance-based cash and equity incentives tied to metrics such as normalized FFO per share, same-store NOI growth, ESG goals, and relative and absolute TSR — appropriately aligns executive interests with long-term stockholder value and supports retention and recruitment (including recent one-time make-whole and retention grants). The Company discloses that a substantial portion of NEO pay is performance-based (over 80% for NEOs, and 65% for the CEO in long-term equity), and that the Committee uses independent advisors, peer group benchmarking, clawback policy, and multi-year vesting and double-trigger change-in-control protections to mitigate misalignment and risk. Company-specific context includes the appointment of a new CEO in 2025, a one-time make-whole restricted stock award to the CEO, significant equity and cash incentive structures tied to multi-year performance periods, and prior strong shareholder support (87.1% say-on-pay in 2025). Because the vote is non-binding, a favorable result signals investor support for the Board’s approach and sustains current program design; a negative result would prompt the Board and Compensation Committee to review and consider changes and to engage with stockholders. The Board recommends FOR because it believes the program rewards performance, aligns pay with the Company’s strategic goals, and is structured to mitigate short-term risk-taking while facilitating retention of key executives. Investors should weigh the Board’s safeguards and performance linkages against potential concerns such as the magnitude of certain one-time awards and overall CEO total compensation when assessing the proposal’s merits. The Company indicates it will carefully consider the outcome of the advisory vote and investor feedback in designing future compensation policies.

Director elections

Nominees on the ballot6

Independent
Tenure on this board
2.1 yrs
Also a director at
Smartrent Inc (SMRT)
Independent
Tenure on this board
4.3 yrs
Also a director at
Civeo Corp (CVEO)
Independent
Tenure on this board
1.6 yrs
Also a director at
Federal Realty Investment Trust (FRT)
Ownership

Top institutional holders10

Latest 13F quarter
1COHEN STEERS, INC.15.1%52,446,482$891M
2VANGUARD PORTFOLIO MANAGEMENT LLC8.3%28,623,399$486M
3BlackRock, Inc.6.4%22,051,061$375M
4STATE STREET CORP4.9%17,069,935$290M
5VANGUARD CAPITAL MANAGEMENT LLC4.5%15,572,090$265M
6BlackRock, Inc.4.2%14,660,104$249M
7Resolution Capital Ltd4.1%14,034,367$238M
8PRICE T ROWE ASSOCIATES INC /MD/3.9%13,565,759$230M
9APG Asset Management US Inc.3.0%10,223,995$175M
10BlackRock, Inc.2.6%9,023,912$153M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Healthcare Realty Trust Inc 2026 annual meeting?
Healthcare Realty Trust Inc (HR) holds its 2026 annual shareholder meeting on Tuesday, May 19, 2026.
What is the record date for the Healthcare Realty Trust Inc 2026 meeting?
The record date for the Healthcare Realty Trust Inc 2026 meeting is Thursday, March 26, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Healthcare Realty Trust Inc's 2026 meeting?
The board is presenting 6 director nominees at the Healthcare Realty Trust Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Healthcare Realty Trust Inc 2026 meeting?
Shareholders will vote on 3 proposals at the Healthcare Realty Trust Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer